Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents

W. B. Tsai, Y. Long, J. R. Park, J. T. Chang, H. Liu, J. Rodriguez-Canales, Niramol Savaraj, Lynn G Feun, M. A. Davies, I. I. Wistuba, M. T. Kuo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Many human malignancies lack de novo biosynthesis of arginine (Arg) as the key enzyme argininosuccinate synthetase 1 (ASS1) is silenced. These tumors acquire ectopic Arg for survival, and depleting this source by Arg-depleting recombinant enzyme ADI-PEG20 results in cell death. Mechanisms underlying Arg auxotrophy in these tumors and how they respond to Arg-auxotrophic stress are poorly understood. Here, we report that an immediate-early event of Arg-auxotrophic response involves reactive oxygen species-mediated secretion of Gas6, which interacts with its receptor Axl and activates the downstream Ras/PI3K/Akt growth signal leading to accumulation of c-Myc by protein stabilization. Arg-auxotrophic challenge also transcriptionally upregulates c-Myc expression, which provides a feedback mechanism to enhance Axl expression. c-Myc is a positive regulator of ASS1, but elevated ASS1 provides a feedback mechanism to suppress c-Myc and Axl. Our results revealed multiple inter-regulatory pathways in Arg-auxotrophic response, consisting of Axl, c-Myc and ASS1, which regulate Arg homeostasis and ADI-PEG20 sensitivity. These pathways provide potential targets for improving the efficacy of treating Arg-auxotrophic tumors using Arg-deprivation strategies.Oncogene advance online publication, 22 June 2015; doi:10.1038/onc.2015.237.

Original languageEnglish (US)
JournalOncogene
DOIs
StateAccepted/In press - Jun 22 2015

Fingerprint

Arginine
Drug Therapy
Argininosuccinate Synthase
Neoplasms
Proto-Oncogene Proteins c-myc
Enzymes
Phosphatidylinositol 3-Kinases
Oncogenes
Publications
Reactive Oxygen Species
Homeostasis
Cell Death
Up-Regulation
Survival
Growth

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Tsai, W. B., Long, Y., Park, J. R., Chang, J. T., Liu, H., Rodriguez-Canales, J., ... Kuo, M. T. (Accepted/In press). Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents. Oncogene. https://doi.org/10.1038/onc.2015.237

Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents. / Tsai, W. B.; Long, Y.; Park, J. R.; Chang, J. T.; Liu, H.; Rodriguez-Canales, J.; Savaraj, Niramol; Feun, Lynn G; Davies, M. A.; Wistuba, I. I.; Kuo, M. T.

In: Oncogene, 22.06.2015.

Research output: Contribution to journalArticle

Tsai, W. B. ; Long, Y. ; Park, J. R. ; Chang, J. T. ; Liu, H. ; Rodriguez-Canales, J. ; Savaraj, Niramol ; Feun, Lynn G ; Davies, M. A. ; Wistuba, I. I. ; Kuo, M. T. / Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents. In: Oncogene. 2015.
@article{9e1d3964acbb4ad0b53053be08c7bf5d,
title = "Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents",
abstract = "Many human malignancies lack de novo biosynthesis of arginine (Arg) as the key enzyme argininosuccinate synthetase 1 (ASS1) is silenced. These tumors acquire ectopic Arg for survival, and depleting this source by Arg-depleting recombinant enzyme ADI-PEG20 results in cell death. Mechanisms underlying Arg auxotrophy in these tumors and how they respond to Arg-auxotrophic stress are poorly understood. Here, we report that an immediate-early event of Arg-auxotrophic response involves reactive oxygen species-mediated secretion of Gas6, which interacts with its receptor Axl and activates the downstream Ras/PI3K/Akt growth signal leading to accumulation of c-Myc by protein stabilization. Arg-auxotrophic challenge also transcriptionally upregulates c-Myc expression, which provides a feedback mechanism to enhance Axl expression. c-Myc is a positive regulator of ASS1, but elevated ASS1 provides a feedback mechanism to suppress c-Myc and Axl. Our results revealed multiple inter-regulatory pathways in Arg-auxotrophic response, consisting of Axl, c-Myc and ASS1, which regulate Arg homeostasis and ADI-PEG20 sensitivity. These pathways provide potential targets for improving the efficacy of treating Arg-auxotrophic tumors using Arg-deprivation strategies.Oncogene advance online publication, 22 June 2015; doi:10.1038/onc.2015.237.",
author = "Tsai, {W. B.} and Y. Long and Park, {J. R.} and Chang, {J. T.} and H. Liu and J. Rodriguez-Canales and Niramol Savaraj and Feun, {Lynn G} and Davies, {M. A.} and Wistuba, {I. I.} and Kuo, {M. T.}",
year = "2015",
month = "6",
day = "22",
doi = "10.1038/onc.2015.237",
language = "English (US)",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents

AU - Tsai, W. B.

AU - Long, Y.

AU - Park, J. R.

AU - Chang, J. T.

AU - Liu, H.

AU - Rodriguez-Canales, J.

AU - Savaraj, Niramol

AU - Feun, Lynn G

AU - Davies, M. A.

AU - Wistuba, I. I.

AU - Kuo, M. T.

PY - 2015/6/22

Y1 - 2015/6/22

N2 - Many human malignancies lack de novo biosynthesis of arginine (Arg) as the key enzyme argininosuccinate synthetase 1 (ASS1) is silenced. These tumors acquire ectopic Arg for survival, and depleting this source by Arg-depleting recombinant enzyme ADI-PEG20 results in cell death. Mechanisms underlying Arg auxotrophy in these tumors and how they respond to Arg-auxotrophic stress are poorly understood. Here, we report that an immediate-early event of Arg-auxotrophic response involves reactive oxygen species-mediated secretion of Gas6, which interacts with its receptor Axl and activates the downstream Ras/PI3K/Akt growth signal leading to accumulation of c-Myc by protein stabilization. Arg-auxotrophic challenge also transcriptionally upregulates c-Myc expression, which provides a feedback mechanism to enhance Axl expression. c-Myc is a positive regulator of ASS1, but elevated ASS1 provides a feedback mechanism to suppress c-Myc and Axl. Our results revealed multiple inter-regulatory pathways in Arg-auxotrophic response, consisting of Axl, c-Myc and ASS1, which regulate Arg homeostasis and ADI-PEG20 sensitivity. These pathways provide potential targets for improving the efficacy of treating Arg-auxotrophic tumors using Arg-deprivation strategies.Oncogene advance online publication, 22 June 2015; doi:10.1038/onc.2015.237.

AB - Many human malignancies lack de novo biosynthesis of arginine (Arg) as the key enzyme argininosuccinate synthetase 1 (ASS1) is silenced. These tumors acquire ectopic Arg for survival, and depleting this source by Arg-depleting recombinant enzyme ADI-PEG20 results in cell death. Mechanisms underlying Arg auxotrophy in these tumors and how they respond to Arg-auxotrophic stress are poorly understood. Here, we report that an immediate-early event of Arg-auxotrophic response involves reactive oxygen species-mediated secretion of Gas6, which interacts with its receptor Axl and activates the downstream Ras/PI3K/Akt growth signal leading to accumulation of c-Myc by protein stabilization. Arg-auxotrophic challenge also transcriptionally upregulates c-Myc expression, which provides a feedback mechanism to enhance Axl expression. c-Myc is a positive regulator of ASS1, but elevated ASS1 provides a feedback mechanism to suppress c-Myc and Axl. Our results revealed multiple inter-regulatory pathways in Arg-auxotrophic response, consisting of Axl, c-Myc and ASS1, which regulate Arg homeostasis and ADI-PEG20 sensitivity. These pathways provide potential targets for improving the efficacy of treating Arg-auxotrophic tumors using Arg-deprivation strategies.Oncogene advance online publication, 22 June 2015; doi:10.1038/onc.2015.237.

UR - http://www.scopus.com/inward/record.url?scp=84932110828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932110828&partnerID=8YFLogxK

U2 - 10.1038/onc.2015.237

DO - 10.1038/onc.2015.237

M3 - Article

JO - Oncogene

JF - Oncogene

SN - 0950-9232

ER -